Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Ablynx raises EUR 100M in bond issue

    Ablynx N.V. (Euronext:ABLX) raised EUR 100 million ($113.9 million) in a private placement of convertible bonds with investors outside the U.S. The bonds mature on May 27, 2020, bear 3.25% interest and convert into …

    Published on 5/21/2015
  • FINANCIAL NEWS: Follow-on roundup: Momenta, Dicerna

    Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) and Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) raised a combined $186.6 million in follow-ons.Biosimilars and complex generics developer Momenta raised $137.8 million through …

    Published on 5/21/2015
  • FINANCIAL NEWS: Osage closes $215M fund

    Osage University Partners closed its Osage University Partners II LP with $215 million, exceeding its target of $200 million. The fund will invest in life science and technology companies spun out from its partner …

    Published on 5/20/2015
  • FINANCIAL NEWS: RegenxBio raises $70.5M series D

    Gene therapy company RegenxBio Inc. (Rockville, Md.) raised $70.5 million in an oversubscribed series D round led by new investor Vivo Capital and existing investors Venrock and Brookside Capital. Other investors …

    Published on 5/20/2015
  • FINANCIAL NEWS: Sarepta shares spike on eteplirsen news

    Sarepta Therapeutics Inc. (NASDAQ:SRPT) soared $9.86 (60%) to $26.24 on Wednesday after the company said late Tuesday it had agreed with FDA on a rolling NDA submission for eteplirsen (AVI-4658) to treat Duchenne …

    Published on 5/20/2015
  • FINANCIAL NEWS: PsiOxus raises L25M in series C

    PsiOxus Therapeutics Ltd. raised L25 million ($39.2 million) in a series C round led by Imperial Innovations Group plc (LSE:IVO) with a L7 million ($11 million) investment. Existing investors Invesco; SROne; …

    Published on 5/19/2015
  • FINANCIAL NEWS: Financial tracks

    TPG hired Heath Lukatch as managing director and partner at its TPG Biotech life sciences venture investment arm. Lukatch previously was a partner at Novo Ventures.Clarus Ventures promoted Michele Park to partner from …

    Published on 5/18/2015
  • FINANCIAL NEWS: Newco OccuRx raises A$6.5M

    OccuRx Pty. Ltd. (Melbourne, Australia) raised A$6.5 million ($5.2 million) in a tranched round of funding from the Medical Research Commercialization Fund; Brandon Capital Partners; and Uniseed. OccuRx's lead candidate…

    Published on 5/18/2015
  • FINANCIAL NEWS: Denali's mountain of money

    Neurodegenerative disease company Denali Therapeutics Inc. (San Francisco, Calif.) raised $217 million in an untranched series A round -- the second largest series A financing in the industry's history. Investors …

    Published on 5/14/2015
  • FINANCIAL NEWS: Galapagos fills till via private placement, U.S. listing

    Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) gained $8.45 (20%) to $50.50 on Thursday in its first day of trading on NASDAQ after it raised $210.1 million through the sale of 5 million ADSs at $42.05. The company also …

    Published on 5/14/2015
  • FINANCIAL NEWS: MPM closes $400 million fund

    MPM Capital closed its BioVentures 2014 fund at $400 million. According to an SEC filing from last spring, MPM was looking to raise about $380 million for the fund. The firm's Luke Evnin told BioCentury that MPM already…

    Published on 5/13/2015
  • FINANCIAL NEWS: NantBioscience raises $100M

    NantBioscience Inc. raised $100 million in equity financing, according to an SEC filing. The money came from a single investor, as have three previous NantBioscience financings documented in regulatory filings. …

    Published on 5/13/2015
  • FINANCIAL NEWS: Navidea takes $60M loan

    Navidea Biopharmaceuticals Inc. (NYSE-M: NAVB) said it will receive a loan of up to $60 million from CRG, including an initial $50 million at closing. Navidea plans to retire its debt from Oxford Finance LLC and …

    Published on 5/13/2015
  • FINANCIAL NEWS: Obesity play Gelesis postpones IPO

    Obesity device developer Gelesis Inc. (Boston, Mass.) postponed its IPO on NASDAQ, which was to be underwritten by Piper Jaffray; Stifel; and Guggenheim. Last month, Gelesis said it hoped to sell 4 million shares at $12…

    Published on 5/13/2015
  • FINANCIAL NEWS: BeiGene raises RMB600M

    Cancer company BeiGene Co. Ltd. (Beijing, China) raised RMB600 million ($96.6 million) in a venture round led by two of its existing investors: Hillhouse Capital and an undisclosed U.S. public investment fund. Also …

    Published on 5/12/2015
  • FINANCIAL NEWS: Financial tracks

    Tech transfer and investment firm NetScientific plc (LSE:NSCI) named Francois Martelet CEO and director. Martelet was senior advisor to the CEO and interim SVP at Stallergenes S.A. (Euronext:GENP).Leerink Partners named…

    Published on 5/12/2015
  • FINANCIAL NEWS: JHL raises $45.6 million series C

    JHL Biotech Inc. (Zhubei, Taiwan) raised $45.6 million in a series C round led by an undisclosed crossover investor. Existing investor Milestone Capital and new investors Sungent BioVenture and Liwick Investment …

    Published on 5/12/2015
  • FINANCIAL NEWS: NewLink nosedives on IMPRESS news

    NewLink Genetics Corp. (NASDAQ:NLNK) lost $15.59 (30%) to $36.55 on Tuesday following Monday's post-market news that it would continue the Phase III IMPRESS trial of HyperAcute Pancreas algenpantucel-L to treat resected…

    Published on 5/12/2015
  • FINANCIAL NEWS: Precision raises $25.6M in series A

    Gene editing company Precision BioSciences Inc. (Durham, N.C.) raised $25.6 million in a series A round led by venBio. Other investors included Fidelity Biosciences; Amgen Ventures; Baxter Ventures; Osage University …

    Published on 5/11/2015
  • FINANCIAL NEWS: Biogen authorizes $5B share buyback

    Biogen Inc. (NASDAQ:BIIB) said its board authorized a stock repurchase program for up to $5 billion of common stock, or about 13 million shares based on Thursday's closing price of $383.29. Biogen expects to complete …

    Published on 5/8/2015
  • FINANCIAL NEWS: aTyr, Collegium rise after IPOs

    aTyr Pharma Inc. (NASDAQ:LIFE) and Collegium Pharmaceutical Inc. (NASDAQ:COLL) each posted gains in their first day of trading Thursday after pricing IPOs.aTyr rose $0.95 to $14.95 after it raised $75 million through …

    Published on 5/7/2015
  • FINANCIAL NEWS: Spyryx raises $18M in series A

    Respiratory newco Spyryx Biosciences Inc. (Research Triangle Park, N.C.) raised $18 million in a series A round from Canaan Partners; Hatteras Venture Partners; and 5AM Ventures. The University of North Carolina spinout…

    Published on 5/7/2015
  • FINANCIAL NEWS: Verseon raises L65.8M in IPO

    Verseon Corp. (LSE:VSN) raised L65.8 million ($99.6 million) through the sale of 32.6 million shares at 202p in an IPO on the London Stock Exchange's AIM, making it the second largest biotech IPO on LSE after Circassia …

    Published on 5/7/2015
  • FINANCIAL NEWS: Adaptive Biotechnologies raises $195M series F

    Adaptive Biotechnologies Corp. (Seattle, Wash.) raised $195 million in a series F round, the third largest disclosed venture round for a biotech this year. Matrix Capital Management led Adaptive's round; other new …

    Published on 5/6/2015
  • FINANCIAL NEWS: IPO roundup: Adaptimmune, CoLucid, OpGen, HTG

    Cancer immunotherapy company Adaptimmune Therapeutics plc (NASDAQ:ADAP), migraine treatment developer CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD), diagnostics company OpGen Inc. (NASDAQ:OPGN), and HTG Molecular …

    Published on 5/6/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993